Bardoxolone methyl：FDA Rejects Bardoxolone Methyl For Chronic Kidney ...

FDA Rejects Bardoxolone Methyl For Chronic Kidney ...

2022年2月28日—ThecompleteresponseletterfromtheFDAcitedalackofeffectivenessinslowingthelossofkidneyfunctioninpatientswithAlportsyndrome.。其他文章還包含有：「Bardoxolonemethyl」、「Bardoxolonemethyl(CDDO」、「Bardoxolonemethyl(RTA402，甲基巴多索隆)」、「BardoxoloneMethyl」、「Bardoxolonemethylanalogattenuatesproteinuria」、「BardoxoloneMethylandKidneyFunctioninCKDwithType...」、「BardoxoloneMet...

查看更多離開網站

Omaveloxolone Reata Pharmaceuticals

Provide From Google

Bardoxolone methyl

https://en.wikipedia.org

Bardoxolone methyl is an experimental and orally-bioavailable semi-synthetic triterpenoid, based on the scaffold of the natural product oleanolic acid.

Provide From Google

Bardoxolone methyl (CDDO

https://www.ncbi.nlm.nih.gov

As a multifunctional agent, CDDO-Me has improved the renal function in patients with chronic kidney disease associated with type 2 diabetes.

Provide From Google

Bardoxolone methyl (RTA 402，甲基巴多索隆)

https://www.medchemexpress.cn

Bardoxolone methyl (NSC 713200; RTA 402; CDDO Methyl ester) 是一种合成的三萜类化合物，具有潜在的抗肿瘤和抗炎活性，作为Nrf2 通路的激活剂和NF-κB 途径的抑制剂。

Provide From Google

Bardoxolone Methyl

https://www.sciencedirect.com

Bardoxolone methyl is a semisynthetic triterpene, which promotes antioxidant response and inhibits pro-inflammatory signals through activating nuclear factor ...

Provide From Google

Bardoxolone methyl analog attenuates proteinuria

https://pubmed.ncbi.nlm.nih.go

Multiple clinical studies have shown that bardoxolone methyl, a potent activator of nuclear factor erythroid 2-related factor 2 (Nrf2), is effective in ...

Provide From Google